Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?
- PMID: 16051942
- DOI: 10.1200/JCO.2005.02.912
Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?
Comment on
-
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.J Clin Oncol. 2005 Aug 1;23(22):5088-93. doi: 10.1200/JCO.2005.03.164. J Clin Oncol. 2005. PMID: 16051955
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
